|Articles|January 18, 2002
What's New on the CBER Web Site 12/24/2001 through 12/28/2001
Author(s)BioPharm International Editors
Recall of reagent red blood cells (two notices) and advisory committee meetings
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4
Novartis Calls for Global Governments to Address Global Trade Policy
5